Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
Bo Xu,Shengxian Tu,Lei Song,Zening Jin,Bo Yu,Guosheng Fu,Yujie Zhou,Jian-an Wang,Yundai Chen,Jun Pu,Lianglong Chen,Xinkai Qu,Junqing Yang,Xuebo Liu,Lijun Guo,Chengxing Shen,Yao-Jun Zhang,Qi Zhang,Hongwei Pan,Xiaogang Fu,Jian K. Liu,Yanyan Zhao,Javier Escaned,Yang Wang,William F Fearon,Kefei Dou,Ajay J. Kirtane,Yongjian Wu,Patrick W. Serruys,Weixian Yang,William Wijns,Changdong Guan,Martin B. Leon,Shubin Qiao,Gregg W. Stone +34 more
TLDR
The FAVOR III China trial as mentioned in this paper showed that a QFR-guided strategy of lesion selection for percutaneous coronary intervention improved 1-year clinical outcomes compared with standard angiography guidance.About:
This article is published in The Lancet.The article was published on 2021-11-04 and is currently open access. It has received 84 citations till now. The article focuses on the topics: Conventional PCI & Acute coronary syndrome.read more
Citations
More filters
Journal ArticleDOI
Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends
Lili Tan,Xiangxiu Wang,Kungshan Yuan,Tieying Yin,Ruolin Du,Li Shen,Zhirong Zhu,Suhua Yu,Haijun Zhang,Guixue Wang +9 more
TL;DR: In this paper , the authors explore the history, research hotspots, and emerging trends of drug-eluting stents (DES) in the last two decades from the perspective of structural and temporal dynamics.
Journal ArticleDOI
Angiography-Based Fractional Flow Reserve: State of the Art
Alessandra Scoccia,Mariusz Tomaniak,Tara Neleman,Frederik Groenland,Annemieke C Ziedses des Plantes,Joost Daemen +5 more
TL;DR: In this paper , the authors summarized the current evidence related to angiography-based fractional flow reserve (FFR) derivation and perspectives on future developments, and provided a comprehensive overview of the current literature.
Journal ArticleDOI
Angiography derived assessment of the coronary microcirculation: is it ready for prime time?
Jinying Zhou,Yoshinobu Onuma,Scot Garg,Nozomi Kotoku,Shigetaka Kageyama,Shinichiro Masuda,Kai Ninomiya,Yunlong Huo,Johan H. C. Reiber,Shengxian Tu,Jan J. Piek,Javier Escaned,Divaka Perera,Christos V. Bourantas,Hongbing Yan,Patrick W. Serruys +15 more
TL;DR: The angiography-derived index of microvascular resistance has emerged as a promising surrogate in pilot studies, however, more data are needed to validate and compare the diagnostic and prognostic accuracy of different equations as well as to illustrate the relationship between angiographic-derived parameters for epicardial coronary arteries and those for the microvasculature.
Journal ArticleDOI
Coronary physiological assessment in the catheter laboratory: haemodynamics, clinical assessment and future perspectives
TL;DR: In this paper , the authors propose a method for quantifying quantification.quantify quantify quantified quantification, quantification quantifier, quantifyquantification quantify.
Journal ArticleDOI
Diagnostic performance of quantitative flow ratio versus fractional flow reserve and resting full-cycle ratio in intermediate coronary lesions.
Hendrik Wienemann,Christopher Ameskamp,Hernán Mejía-Rentería,Victor Mauri,Christopher Hohmann,Stephan Baldus,Matti Adam,Javier Escaned,Marcel Halbach +8 more
TL;DR: In this article , the diagnostic performance of contrast flow and fixed flow (fQFR) QFR against the NHPR resting full-cyle ratio (RFR) using FFR as reference standard was investigated.
References
More filters
Journal ArticleDOI
Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics: The PANDA III Trial.
Bo Xu,Runlin Gao,Yuejin Yang,Xuebin Cao,Lei Qin,Yi Li,Zhanquan Li,Xueqi Li,Hailong Lin,Yong Guo,Yi-Tong Ma,Jian-an Wang,Shaoping Nie,Liang Xu,Eric Cao,Changdong Guan,Gregg W. Stone +16 more
TL;DR: The BuMA SES was demonstrated to be noninferior to the Excel SES for 1-year TLF, with a lower incidence of stent thrombosis, with no significant between-group differences in any of the secondary endpoints.
Journal ArticleDOI
Novel Indices of Coronary Physiology: Do We Need Alternatives to Fractional Flow Reserve?
Giovanni Luigi De Maria,Hector M. Garcia-Garcia,Roberto Scarsini,Alexandre Hideo-Kajita,Nieves Gonzalo López,Antonio Maria Leone,Giovanna Sarno,Joost Daemen,Evan Shlofmitz,Allen Jeremias,Matteo Tebaldi,Hiram G. Bezerra,Shengxian Tu,Pedro A. Lemos,Yuichi Ozaki,Kazuhiro Dan,Carlos Collet,Adrian P. Banning,Emanuele Barbato,Nils P. Johnson,Ron Waksman +20 more
TL;DR: This review article provides a critical description of the currently available or under-development alternatives to fractional flow reserve with a special focus on the available evidence, pros, and cons for each with a view towards their clinical application in the near future for the functional assessment of coronary artery disease.
Journal ArticleDOI
Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial.
Lei Song,Shengxian Tu,Zhongwei Sun,Yang Wang,Daixin Ding,Changdong Guan,Lihua Xie,Javier Escaned,William F. Fearon,Ajay J. Kirtane,Patrick W. Serruys,William Wijns,Stephan Windecker,Martin B. Leon,Gregg W. Stone,Shubin Qiao,Bo Xu +16 more
TL;DR: The FAVOR III China study will be the first randomized trial to examine the effectiveness and cost-effectiveness of a QFR-guided versus an angiography-guided PCI strategy in coronary artery disease patients.